Cronos Group CRON

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$0 (+0.00%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

Key Insights

Cronos Group (CRON) Core Market Data and Business Metrics
  • Latest Closing Price

    $1.81
  • Price-Earnings Ratio

    -15.08
  • Total Outstanding Shares

    382.53 Million Shares
  • Dividend

    No dividend
  • SIC Description

    Medicinal Chemicals & Botanical Products
  • Primary Exchange

    NASDAQ
  • Headquarters

    4491 Concession Rd 12, Stayner, A6, L0M 1S0

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Short Interest

Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
Avg Daily VolumeDays to CoverSettlement DateShort Interest
1,625,872 Shares2.783/14/20254,518,742 Shares
1,791,721 Shares2.542/28/20254,542,655 Shares
2,039,947 Shares2.022/14/20254,111,697 Shares
1,179,762 Shares3.21/31/20253,773,524 Shares
1,546,756 Shares2.21/15/20253,396,811 Shares
1,401,303 Shares2.3512/31/20243,291,830 Shares

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow From Investing Activities, Continuing$262.07 Million
Net Cash Flow From Operating Activities$27.94 Million
Net Cash Flow From Financing Activities, Continuing$-1.14 Million
Net Cash Flow From Financing Activities$-1.14 Million
Net Cash Flow From Operating Activities, Continuing$27.94 Million
Net Cash Flow From Investing Activities$262.07 Million

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Preferred Stock Dividends And Other Adjustments$0
Income/Loss Before Equity Method Investments$-57.99 Million
Income/Loss From Continuing Operations After Tax$-49.07 Million
Diluted Average Shares$382.03 Million
Revenues$111.23 Million
Income/Loss From Equity Method Investments$3.12 Million

Comprehensive Income

October 1, 2023 to September 30, 2024
MetricValue
Comprehensive Income/Loss$-46.42 Million
Comprehensive Income/Loss Attributable To Parent$-45.69 Million
Comprehensive Income/Loss Attributable To Noncontrolling Interest$-734,000
Other Comprehensive Income/Loss$2.52 Million

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Noncurrent Liabilities$13.26 Million
Assets$1.18 Billion
Other Current Assets$911.92 Million
Fixed Assets$162.52 Million
Current Liabilities$39.56 Million
Current Assets$959.17 Million

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Recent Headlines From The Web

Latest news, press releases, and media coverage about CRON from trusted financial sources

    Related Companies

    Publicly traded companies similar to Cronos Group (CRON)